News

Ophthalmology Times7h
PulseSight doses first patient in PST-611-CT1
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Ophthalmology Times21h
Beacon Therapeutics completes enrollment in phase 2/3 VISTA trial
The VISTA trial is evaluating and comparing 2 dose levels of laru-zova with an untreated control group for the treatment of X ...
Ophthalmology Times20h
50 years of ophthalmology: What changed the game (Part 1)
In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations ...